Authors:
HANDE K
WILDING G
RIPPLE G
FRY J
ARZOOMANIAN R
DIXON M
YUEN G
COLLIER M
Citation: K. Hande et al., A PHASE-I STUDY OF AG3340, A MATRIX METALLOPROTEASE (MMP) INHIBITOR, IN PATIENTS HAVING ADVANCED CANCER, Annals of oncology, 9, 1998, pp. 279-279
Authors:
WILDING G
SMALL E
RIPPLE G
KELLER M
YUEN G
COLLIER M
Citation: G. Wilding et al., PHASE-I STUDY OF AG3340, A MATRIX METALLOPROTEASE INHIBITOR, IN COMBINATION WITH MITOXANTRONE PREDNISONE IN PATIENTS HAVING ADVANCED PROSTATE-CANCER/, Annals of oncology, 9, 1998, pp. 280-280
Authors:
PHILLIPS AN
ERON J
BARTLETT J
KURITZKES DR
JOHNSON VA
GILBERT C
JOHNSON J
KELLER A
HILL AM
AKIL B
BEALL G
BELLOS N
BERRY P
BRUMMIT C
CAMERON B
COHEN C
DONABEDIAN H
MAYAR K
MCKINLEY G
SEPULVEDA G
THOMPSON M
TSOUKAS C
WALMSLEY S
HORTON J
KERKERING T
MATTHEW E
PEARCE D
PETERSON D
POTTAGE J
SAMPSON J
SMITH W
YANGCO B
COWAN J
KACZKA C
ZAMECK R
DAWSON D
POBINER B
SCOTTLENNOX J
DEMASI R
JARRETT P
YUEN G
ESINHART J
QUINN J
FALLON MA
BENOIT S
Citation: An. Phillips et al., CORRESPONDENCE BETWEEN THE EFFECT OF ZIDOVUDINE PLUS LAMIVUDINE ON PLASMA HIV LEVEL CD4 LYMPHOCYTE COUNT AND THE INCIDENCE OF CLINICAL-DISEASE IN INFECTED INDIVIDUALS, AIDS, 11(2), 1997, pp. 169-175
Citation: P. Staswick et al., JASMONATE SIGNALING IS INVOLVED IN RESISTANCE TO PYTHIUM IRREGULARE IN ARABIDOPSIS-THALIANA, Plant physiology, 114(3), 1997, pp. 1458-1458
Authors:
PHILLIPS AN
ERON JJ
BARTLETT JA
RUBIN M
JOHNSON J
PRICE S
SELF P
HILL AM
AKIL B
BEALL G
BELLOS N
BERRY P
BRUMMIT C
CAMERON B
COHEN C
DONABEDIAN H
MAYAR K
MCKINLEY G
SEPULVEDA G
THOMPSON M
TSOUKAS C
WALMSLEY S
HORTON J
KERKERING T
MATTHEW E
PEARCE D
PETERSON D
POTTAGE J
SAMPSON J
SMITH W
YANGCO B
COWAN J
KACZKA C
ZAMECK R
DAWSON D
POBINER B
GILBERT C
SCOTTLENNOX J
DEMASI R
JARRETT P
YUEN G
ESINHART J
QUINN J
FALLON MA
BENOIT S
Citation: An. Phillips et al., HIV-1 RNA LEVELS AND THE DEVELOPMENT OF CLINICAL-DISEASE, AIDS, 10(8), 1996, pp. 859-865
Authors:
LEWIS LL
VENZON D
CHURCH J
FARLEY M
WHEELER S
KELLER A
RUBIN M
YUEN G
MUELLER B
SLOAS M
WOOD L
BALIS F
SHEARER GM
BROUWERS P
GOLDSMITH J
PIZZO PA
ANDERSON B
HIRSCHFELD S
SEI S
ZEICHNER S
ROILIDES E
CLERICI M
WELLS M
STOCKER V
HIGHAM C
TOWNLEY E
WALSEK C
ZWERSKI S
HEILMAN N
SELKINGUTMAN G
WOLTERS P
MOSS H
JAROSINSKI P
Citation: Ll. Lewis et al., LAMIVUDINE IN CHILDREN WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - A PHASE I II STUDY/, The Journal of infectious diseases, 174(1), 1996, pp. 16-25
Authors:
MOORE K
RAASCH R
YUEN G
ERON J
MARTIN D
HUSSEY E
Citation: K. Moore et al., PHARMACOKINETICS (PK) OF LAMIVUDINE (3TC) ADMINISTERED ALONE AND WITHORAL TRIMETHOPRIM (TMP) PLUS SULFAMETHOXAZOLE (SMX) IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INFECTION, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 143-143
Authors:
DRUSANO GL
FORREST A
YUEN G
PLAISANCE K
LESLIE J
Citation: Gl. Drusano et al., OPTIMAL SAMPLING THEORY - EFFECT OF ERROR IN A NOMINAL PARAMETER VALUE ON BIAS AND PRECISION OF PARAMETER-ESTIMATION, Journal of clinical pharmacology, 34(10), 1994, pp. 967-974
Authors:
HORTON CM
YUEN G
MIKOLICH DM
FISHER A
RANA K
MYDLOW P
DUDLEY MN
Citation: Cm. Horton et al., PHARMACOKINETICS (PK) OF ORAL LAMIVUDINE ADMINISTERED ALONE WITH ORALZIDOVUDINE (ZDV) IN ASYMPTOMATIC PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INFECTION, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 198-198